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Abstract
Background: De novo retrotransposition of Alu elements has been recognized as a major driver for insertion
polymorphisms in human populations. In this study, we exploited Alu-anchored bisulfite PCR libraries to identify
evolutionarily recent Alu element insertions, and to investigate their genetic and epigenetic variation.
Results: A total of 327 putatively recent Alu insertions were identified, altogether represented by 1,762 sequence
reads. Nearly all such de novo retrotransposition events (316/327) were novel. Forty-seven out of forty-nine
randomly selected events, corresponding to nineteen genomic loci, were sequence-verified. Alu element insertions
remained hemizygous in one or more individuals in sixteen of the nineteen genomic loci. The Alu elements were
found to be enriched for young Alu families with characteristic sequence features, such as the presence of a
longer poly(A) tail. In addition, we documented the occurrence of a duplication of the AT-rich target site in their
immediate flanking sequences, a hallmark of retrotransposition. Furthermore, we found the sequence motif (TT/
AAAA) that is recognized by the ORF2P protein encoded by LINE-1 in their 5’-flanking regions, consistent with the
fact that Alu retrotransposition is facilitated by LINE-1 elements. While most of these Alu elements were heavily
methylated, we identified an Alu localized 1.5 kb downstream of TOMM5 that exhibited a completely
unmethylated left arm. Interestingly, we observed differential methylation of its immediate 5’ and 3’ flanking CpG
dinucleotides, in concordance with the unmethylated and methylated statuses of its internal 5’ and 3’ sequences,
respectively. Importantly, TOMM5’s CpG island and the 3 Alu repeats and 1 MIR element localized upstream of this
newly inserted Alu were also found to be unmethylated. Methylation analyses of two additional genomic loci
revealed no methylation differences in CpG dinucleotides flanking the Alu insertion sites in the two homologous
chromosomes, irrespective of the presence or absence of the insertion.
Conclusions: We anticipate that the combination of methodologies utilized in this study, which included repeat-
anchored bisulfite PCR sequencing and the computational analysis pipeline herein reported, will prove invaluable
for the generation of genetic and epigenetic variation maps.
Background
Repetitive elements constitute over 50% of the human
genomic sequence [1]. The most prevalent repeats are
the Alu family of SINEs, which comprise approximately
10% of the human genome. A typical Alu element is
approximately 300 bp long and contains two almost
identical arms separated by an A-rich sequence. The
ancestor of the Alu monomer is the 7 SL RNA gene,
which encodes the RNA component of the signal recog-
nition particle (SRP) that is involved in the translocation
of newly synthesized proteins [2,3]. Similar to the 7 SL
gene, Alu elements with intact promoters - namely A
and B boxes - may be transcribed by RNA polymerase
III [2,4]. With the aid of the LINE-encoded retrotran-
sposition machinery, Alu transcripts gain mobility and
expand in genomes through a process involving reverse
transcription and integration [5].
Alu retrotransposition has been an important molecu-
lar evolutionary force reshaping the primate genomes
[6]. The expansion of the Alu elements in the primate
genomes is dated at least 60 million years ago [7]. Based
on their evolutionary history, Alu elements can be clas-
sified in three major subfamilies: AluJ, AluS, and AluY
[8]. Among them, the youngest Alu elements - AluY
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bit the highest rate of retrotransposition in the human
genome [9-12]. While several recent studies have shown
that LINE-1 elements contribute substantially to the
structural variations observed in the human genome
[13-15], the retrotransposition rate of Alu elements is
ten times higher than that of LINE-1, with an estimated
new insertion at every 21 births [16].
Decades of research have demonstrated that Alu ele-
ments play important roles in the genome and tran-
scriptome [17-20]. Alu elements may contribute a large
number of transcription factor binding sites [21], some
of which may serve as enhancers involved in tissue
development [22,23]. In addition, some Alu elements
may be expressed and Alu transcription affects nearby
gene expression, distal gene expression, and global
translation. For instance, the expression of an Alu in the
promoter of an epsilon-globin gene was found to nega-
tively regulate globin gene expression by transcriptional
interference [24]. Recently, Alu RNA was found to be a
modular transacting repressor of mRNA transcription
[25]. Interestingly, such transcriptional suppression was
found to be specific and limited to certain genes. Alu
RNAs also affect translational initiation and were found
to form stable, discrete complexes with the double-
stranded RNA-activated kinase PKR, and to antagonize
PKR activation [26]. Transcription derepression of
otherwise active Alu elements, which so often reside
within genes, may lead to the formation of double-
strand RNA - if in antisense orientation - and ultimately
to heterochromatinization and silencing of the gene
[27].
O n eo ft h ek e ym e c h a n i s m sc o n t r o l l i n gA l ue x p r e s -
sion is DNA methylation. The human genome has
approximately 28 million CpG dinucleotides, 7 million
of which are found within Alu elements [1]. In most
somatic tissues, the CpG dinucleotides within the Alu
sequence are heavily methylated to suppress Alu expres-
sion [28,29]. It has been demonstrated that the A and B
boxes (5-16 bp, and 75-84 bp from the 5’ terminus,
respectively) are critical cis-elements for Alu expression.
In particular, methylation of the B box is thought to
inhibit protein binding and hence block Alu transcrip-
tion [30]. Albeit not sufficient, demethylation and conse-
quently transcription of Alu elements is required for
occurrence of de novo retrotransposition [28]. Methy-
lated CpGs can undergo deamination and thereby lead
to mutations that render them unable for retrotransposi-
tion [8,9].
Although much effort has been made to identify struc-
tural variations resulting from Alu integration, much
less is known with regard to the epigenetic status of
newly inserted elements and of their flanking genomic
sequences. Here we report the utilization of an Alu-
anchored bisulfite PCR strategy to generate methylation
maps for thousands of Alu elements in human cerebel-
lum and in ependymomas [31,32]. In this approach,
most of the targeted Alu elements are members of the
active AluY subfamilies. In this study, we analyzed the
aforementioned datasets to identify newly integrated Alu
elements, to investigate sequence characteristics and
commonalities of their integration sites, to uncover their
methylation statuses, and to determine whether the
methylation patterns of the sequences surrounding their
integration sites would be altered in the alleles harbor-
ing the insertion in individuals hemizygous for the Alu
retrotransposon.
Results
Identification of recent Alu insertions
The method developed by Xie and colleagues was initi-
ally designed to generate a methylation map for a subset
of young Alu elements [32]. The strategy applied a pri-
mer targeting CpG-rich Alu repeats to simultaneously
amplify thousands of Alu elements and their 5’ flanking
sequences. Unequivocal mapping of these repeats was
therefore achieved through their - most often unique -
5’ flanking sequences. Eight Alu libraries were derived
with this strategy, six from ependymomas and two from
normal brain tissues [31,32].
In previous studies, a number of sequence reads from
these libraries could only be partially mapped to the
human reference sequence. In order to determine
whether any of these sequence reads corresponded to a
novel Alu integration event, i.e. one that was not yet
documented in the UCSC database, we designed a com-
putational pipeline to reanalyze these datasets (Figure
1). For 158,591 sequence reads partially mapped in pre-
vious studies, we first masked Alu sequences and then
selected the ones containing at least 40 bp of 5’ flanking
sequences. A total of 24,820 sequence reads were thus
identified. The Alu flanking sequences were then
extracted from these reads and subjected to Megablast
against in silico bisulfite converted human reference
genome sequence. Unambiguous mapping was achieved
for 8,738 sequence reads. As expected, the majority of
these reads (79.8%) mapped to genomic sequences adja-
cent to an Alu element. Further examination of the
remaining 1,762 sequences reads (Additional File 1,
Table S1) enabled their grouping into 327 clusters
according to their genomic coordinates (Additional File
2, Table S2). It is noteworthy that due to the highly
stringent mapping criteria applied in our previous stu-
dies [31,32], a few mismatches in the alignments
between the reference genomic sequence and the
sequences generated from the Alu libraries were suffi-
cient to lead to their classification as “partially mapped”
reads.
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comprised of 1,762 sequences reads in eight Alu-
anchored bisulfite PCR libraries (Table 1). Out of 327
clusters, 163 clusters (49.8%) were found to be sup-
ported by more than one sequence read and 87 clusters
(26.7%) were found to be present in more than one
library. Among these 87 clusters, 56 clusters (64.4%)
were found in both normal and tumor tissues. This indi-
cates that a majority of these putative insertions are not
associated with tumorigenesis and/or cancer progres-
sion. In addition, a library derived from a normal brain
tissue contributed 159 clusters (48.6% of the total 327
clusters) with 692 sequence reads (39.3% of 1,762 total
sequence reads), while a library derived from a relapsed
aggressive ependymoma only contributed 16 clusters
with 23 sequence reads. Based on the difference in num-
ber of sequence reads generated from each library, we
normalized - for each library - the number of putative
insertions that were identified, to the number of Alu
repeats that were successfully mapped to the reference
genome. No significant difference was observed in this
ratio between normal and tumor tissues (p = 0.34, t-
Test).
To investigate whether these putatively new Alu inser-
tions had been identified in previous studies, we
extracted 1,763 and 795 known polymorphic Alu ele-
ments from dbSNP (The Single Nucleotide Polymorph-
ism database, NCBI) [33] and dbRIP (Database of
24,820 sequences containing at least 40bp 
non-Alu sequences
8,738 sequences unambiguously mapped to in 
silicobisulfite converted reference genome 
1,762 sequences (327 clusters) with a putative insertion 
site at least 10 bp from the most adjacent Alu
158,591 sequences partially mapped 
in previous studies
316 clusters identified as putative novel Alu 
integrations (not present in either dbSNPor dbRIP)
Figure 1 Computational pipeline developed to identify putative Alu insertions from Alu anchored bisulfite PCR libraries.
Table 1 327 clusters comprised in 1,762 sequence reads.
Sample ID* NC1 NC2 PA1 PA2 PA3 PA4 PA5 RL Sum
sequenceRead_mapped 245,825 460,438 256,014 238,633 336,103 283,730 276,505 245,600 2,342.848
genomeRegion_mapped 31,871 47,071 31,683 33,760 41,485 33,937 33,052 36,957 289,816 (140,865**)
sequenceRead_Alu insertion 56 692 78 216 453 203 23 41 1,762
genomeRegion_Alu insertion 28 159 36 61 113 62 16 23 498 (327**)
Ratio (genomeRegion_AluInsertion/
genomeRegion_mapped)
0.09 0.34 0.11 0.18 0.27 0.18 0.05 0.06
*NC1: normal cerebellum; and NC2: normal 4
th ventricle lining tissue; PA1, PA2, PA3, PA4, and PA5: primary ependymoma tumor; RL: ependymoma tumor
relapsed from PA3.
**Number of non-redundant clusters.
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tively. This analysis revealed that 316 of the 327 clusters
were novel, i.e. they corresponded to yet undocumented
de novo retrotransposition events. The putative integra-
tion sites of 140 of such clusters (42.8%) were found to
localize to intronic regions, except for one, which
mapped to the 3’-UTR of TOMM40, a gene that codes
for the translocase of the mitochondrial outer mem-
brane (TOM) complex. We further analyzed these genes
with NCBI’s DAVID functional annotation tool to
examine whether any specific gene category was more
likely to harbor these Alu insertions. One hundred
thirty-two genes were found annotated in the NCBI
database. Compared to all genes annotated in the
human genome, no significant enrichment was identified
for this set of 132 genes in terms of biological process,
cellular localization or molecular function (Additional
File 2, Table S2).
Verification of recent Alu insertions
To validate the evolutionarily recent Alu de novo retro-
transposition events identified in this study, we ran-
domly selected twenty-one genomic loci encompassing
such putative new Alu insertions. For each genomic
locus, we designed primers based on the upstream and
downstream sequences surrounding the predicted inte-
gration sites. With these primers, the PCR products
were expected to be ~120 bp (without Alu insertion) or
~420 bp (with Alu insertion). Due to the diploidy of the
human genome, three kinds of PCR results were
expected: (1) hemizygous Alu insertion: PCR products
of two different sizes were expected, one fragment with
the Alu insertion and another without it (spanning ~420
bp and ~120 bp, respectively); (2) homozygous Alu
insertion: only one PCR product was expected, this frag-
ment containing an Alu element (spanning ~420 bp);
(3) nulizygous Alu insertion: no Alu insertion was pre-
sent in either homologous chromosome, hence just one
small PCR product (spanning ~120 bp) was expected.
The Alu insertions were successfully verified for forty-
seven out of forty-nine cases representing nineteen geno-
mic loci (Figure 2). To ensure that the regions amplified
by PCR were indeed new Alu insertions, for each locus,
PCR products were cloned and sequence-verified. The
sequences representing these nineteen genomic loci were
submitted to GenBank. Their accession numbers are:
[HQ709117, HQ709118, HQ709119, HQ709120,
HQ709121, HQ709122, HQ709123, HQ709124,
HQ709125, HQ709126, HQ709127, HQ709128,
HQ709129, HQ709130, HQ709131, HQ709132,
HQ709133, HQ709134, HQ709135]. Fourteen out of the
nineteen insertion events were predicted to occur in more
than one individual. Interestingly, we found that nine out
of these fourteen insertions were hemizygous in all
individuals examined - i.e., the Alu insertion only occurred
in one of the two homologous chromosomes. The remain-
ing five insertions were hemizygous for some individuals
and homozygous for others. From a total of forty-seven
Alu insertions, thirty-six were found to be hemizygous
and eleven were found to be homozygous. The fact that
the majority of the insertions have remained in hemizygos-
ity in the genome may be interpreted as suggestive of their
recent evolutionary origin. However, that will remain spec-
ulative until populational studies are performed.
Genomic features and sequence characteristics of Alu
elements and their flanking sequences
It has been shown that polymorphic Alu elements and
their flanking sequences may share some distinct sequence
features [34,35]. The Alu transcripts derived from the ones
with conserved structure would interact productively with
SRP9/15 host proteins and gain the ability to retrotran-
spose [12]. The AluY subfamily and its variants Yc1, Yc2,
Ya5, Ya5a2, Ya8, Yd8, Yb8, and Yb9, are the ones consid-
ered to be very active due to the conservation of its struc-
ture. To conclude the analysis, we classified the Alu
elements identified in this study according to its family of
origin. We found that the new insertions identified in this
study belong to the relatively recent family of AluY ele-
ments or to the subfamilies AluYa5, AluYb8, AluYb9, and
AluYg6. It has also been shown that the occurrence of a
longer poly(A) tail might facilitate Alu retrotransposition
[35]. Our analysis revealed that all twenty-two new Alu
insertions that were sequence verified in this study have
an A-tail that ranged from 11 to 45 nucleotides, with an
average length of 29 bp.
Alu retrotransposition is facilitated by LINE-1 ele-
ments. LINE elements encompass two open reading
frames, namely ORF1 and ORF2P. ORF1 encodes a
non-specific RNA binding protein, and ORF2P encodes
an endonuclease and a reverse transcriptase. During the
process of retrotransposition ORF2P cleaves genomic
DNA at a degenerate consensus sequence (TT/AAAA).
Accordingly, the presence of a TT/AAAA sequence
motif in the 5’-flanking region seems essential for Alu
insertion [5,36,37]. The Alu insertion site is generated
by a single-strand break that occurs in the target DNA
made by ORF2P. The mechanism of Alu insertion is
called Target Primed Reverse Transcription (TPRT)
[8,37]. Indeed, we were able to document the occur-
rence of this sequence motif - either a perfect match or
ah i g h l ys i m i l a rs e q u e n c e-i nt h e5 ’ flanking regions of
all new Alu insertions that were sequence-verified in
this study. For the nineteen Alu insertions identified in
this study, the characteristic sequence features of Alu
and flanking sequences are summarized in Table 2.
In addition to the Alu sequence itself, the genomic
sequence adjacent to the recent Alu insertions
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of a recent retrotransposition event, the sequences
immediately flanking the Alu elements corresponded to
short direct repeats, ranging from 4-17 nucleotides. The
insertion mechanism generates direct target site duplica-
tions (TSDs) flanking the newly inserted element. These
TSDs have variable length and are highly suggestive of
LINE mediated endonucleolytic cleavage [12,38]. Such
short direct repeats, also called AT-rich target site
duplications, were present in 19 of the sequence-verified
genomic loci (Table 2).
Methylation status of recent Alu elements
All sequences generated in our previous studies, encom-
passing Alu elements and their 5’ flanking sequences,
were derived from bisulfite converted genomic DNA
[31,32]. Due to the high frequency of C-to-T transitions
in CpG dinucleotides of Alu repeats caused by deamina-
tion of the methylated cytosines, in the absence of a
reference genomic sequence, one cannot determine the
methylation status of a novel Alu insertion by this
method. Hence, to examine the methylation pattern of
the newly integrated Alu elements, we aligned the
sequences generated in this study for nineteen of such
Alu elements with their bisulfite converted sequences
from our previous studies [31,32] (Additional File 3, Fig-
ure S1). Our results showed that the recently inserted
Alu elements are heavily methylated, with an average
methylation level of 90.7%; this is similar to the average
methylation level observed for evolutionarily young non-
Figure 2 PCR validation of putative Alu insertions (a-g). The Alu insertions were sorted based on genomic coordinates. The Alu insertions
were named AI1 through AI21. N-normal brain tissue DNA; E1, E2, and E3-brain tumor tissue (ependymoma) DNA from different individuals; P
and R- ependymoma DNA, P is primary and R is relapsed tumor from the same individual.
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the methylation status of the two important promoter
regions inside the Alu elements, the A and B boxes. Alu
elements have a bipartite structure, which is similar to
that of tRNA elements. It has been shown that the A
box is responsible for determining the strength of the
Pol III promoter and the B box is important in enabling
transcription [30,39]. Also, deletion of the B box
sequence completely abolished transcription of the ele-
ments, while deletion of the A box reduced the
efficiency of transcription [40]. In almost all cases, these
promoter sequences were methylated (Additional File 3,
Figure S1). This result suggests that transcription of
most newly inserted Alu elements is suppressed by
DNA methylation.
Interestingly, we found one Alu element at
chr9:37594172-37594310 with a completely unmethy-
lated 5’-end (AI19, Additional File 3, Figure S1). Since
amongst all Alu elements chosen for verification this
was the only element found to be unmethylated, and
Table 2 Sequence features of newly inserted Alu repeats.
Sample Chromosome
coordinate
Alu
subfamily
TSD Putative
cleavage
site
Poly-A sequence
AI-1 chr15:61216453-
61216621
AluY AAGAAATGTTCT TTAA CTCAAAAAAAAAAAAAAAGAAAAAAAAAAAAGAAAAAAGAAAT
AI-2 chr5:139595078-
139595241
AluYb8 TAAATTACAGA TTAAA CTCAAAAAAAAAAAAAAAATAAATAAATAAATAAATTA
AI-3 chr4:41598260-
41598327
AluY AAGTACATGTGG TGGAA CTCAAAAAAAAAAAAAAAAAAAAAAAAAAAAAGAAGT
AI-4 chr13:23662855-
23663027
AluYa5 CATCTG TTAAAA CTCCGTCTCAAAAAAAAAAAAAACAAAAAAAAAAACAAAAAAAAAAAACATCT
AI-5 chr15:28179309-
28179438
AluY ATAAAACATGGTCTG TATAAAA CTCAAAAAAAAAAAAAAAATAAAAAAAAATAAATAAAAAAATAAAACAT
AI-6 chr12:32076361-
32076491
AluYg6 GAAATAATTGATCT TGAAA CTCAAAAAAAAAAAAAAAAAAAAAGAAATAAT
AI-7 chr11:130675880-
130675924
AluY AAAAAGAAGC TTAAAA CTCAAAAAAAAAAAAAAAAAAAAGAAGCA
AI-8 chr5:141758572-
141758694
AluYb8 AAAAATGGGGATT TTAAAA CTCAAAAAAAAAAAAAAAAAATGGGGA
AI-9 chr10:107891481-
107891638
AluYg6 CGTGTGCTC TTAAAA CTCAAAAAAAAAAACGTGTG
AI-10 chr10:72605338-
72605440
AluYg6 AAGAAGGTA TAA CTCAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAGAAGGT
AI-11 chr2:48276482-
48276601
AluYb8 AGAAATTCAAATGCA TTA CTCAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAGAAAT
AI-12 chr5:16716576-
16716677
AluYg6 AAGAAGTATGACAG TAA CTCAAAAAAAAAAAAAAAAAAAAGAAGTAT
AI-13 chr12:24518543-
24518646
AluY AAAAAAGTATTAATCA TTAAAA CTCAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAGTAT
AI-14 chr6:57403535-
57403610
AluY TCCTA TAAT CTCAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAATTCC
AI-15 chr2:9888790-
9888862
AluYb8 CACACCCGTG TAA CTCAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACACAC
AI-16 chr9:1631754-
1631884
AluYb8 AAGAA CAAA CTCAAAAAAAAAAAAAAAAAAAAAGAAAACA
AI-17 chr4:139225139-
139225274
AluY GAGTTTTTAAACATCT TTAAA CTCAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAGGAGT
AI-18 chr2:26623669-
26623732
AluYb8 AAAATCAGTTCTTCC TTAAAA CTCAAAAAAAAAAAAAAAAAAAAAAAAAAAAAATCAGTT
AI-19 chr9:37594172-
37594310
AluY AAGAAGTAGATATGG TAA CTCCAAAAAAAAAAAAAAGAAG
AI-20 chr6:99872263-
99872632
--- -
AI-21 chr2:145175223-
145175483
--- -
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previously generated for this element [31,32], we
designed bisulfite PCR primers to amplify the entire Alu
element including the two flanking CpG dinucleotides
(Figure 3). Indeed, the 5’-end of this newly inserted Alu
element was found to be completely unmethylated while
its 3’-end exhibited some degree of DNA methylation. It
is noteworthy that the 5’-flanking CpG site was comple-
tely unmethylated, and the 3’-flanking CpG site was
completely methylated. Importantly, the 5’ terminal
nucleotide of this newly inserted Alu element mapped
1,576 bp downstream from a CpG island and 1,674 bp
downstream from the transcription start site of the
TOMM5 gene. This result suggests that the methylation
status of this Alu element is under the influence of the
epigenetic environment surrounding its insertion site.
Since this Alu insertion was found to be in homozygos-
ity, i.e. it was present in the two homologous chromo-
somes, we were not able to investigate whether the Alu
insertion exerted any influence on the methylation sta-
tus of CpG dinucleotides flanking the Alu element. To
confirm our hypothesis that the methylation of the Alu
element is under the influence of the CpG island, we
ascertained the methylation status of a fragment
(chr9:37592324-37592701) corresponding to the 5’ term-
inal 377 bp of the CpG island, and also of the AluJo ele-
ment flanking the 3’end (chr9:37594745-37595002) of
the newly identified Alu element that was partially
methylated. Indeed, we found that this CpG island
fragment was completely unmethylated while the AluJo
sequence flanking the 3’end of the newly inserted Alu
exhibited a methylation level of the order of 40%. Inter-
estingly, this AluJo exhibited a pattern of methylation
very similar to the pattern presented by the newly
inserted Alu element (Figure 3). There are 3 Alu repeats
and 1 MIR element localized between the newly inserted
Alu and the CpG island. The methylation levels of these
elements are indeed very low (Figure 3).
We conducted similar analysis to two other genomic
loci, chr10:72605338-72605440 and chr2:48276482-
48276601, which were randomly chosen. The Alu inser-
tions on these two loci were found to be in hemizygos-
ity. This allowed us to compare the methylation status
of the alleles with and without the Alu insertion (Figure
4). The sequencing results derived from bisulfite-PCR
cloning demonstrated that both newly inserted Alu ele-
ments were indeed heavily methylated, as anticipated
based upon our previously generated high-throughput
bisulfite sequencing data (AI10 and AI11, Additional
File 3, Figure S1). In addition, for the two genomic loci
examined, there was no methylation difference between
the alleles with and without the Alu insertion in the two
homologous chromosomes, nor was there a difference
in the methylation statuses of the CpG dinucleotides
flanking the chr2:48276482-48276601 Alu insertion site.
Furthermore, the CpG dinucleotide that is immediately
downstream of the chr10:72605338-72605440 Alu inser-
tion site was also found to be methylated. Due to the
Figure 3 Bisulfite PCR cloning and sequencing to validate methylation status of an unmethylated Alu insertion (chr9:37594172-
37594310). Asterisk indicates the CpG dinucleotides that are flanking the Alu element; the scheme shows the relative location of TOMM5 and
the CpG island in relation to the Alu AI19 insertion (USCS Genome Bioinformatics). a) methylation status of a downstream AluJo (sequence
coordinates: chr9:37594745-37595002) near the newly inserted Alu element; b) newly inserted Alu element and its methylation status; c)
methylation status of 2 CpGs upstream of the newly inserted Alu; d), e), f), and g) methylation statuses of 3 Alu repeats and 1 MIR element
localized between the newly inserted Alu and the CpG island, respectively, AluSx, AluJo, MIRb, and AluSx; h) methylation status of the 5’end of a
CpG island located 1,576 bp (sequence coordinates: chr9:37592324-37592701) upstream from the newly inserted Alu element. Note that the
TOMM5 transcription unit is in opposite orientation to that of the newly inserted Alu element. The methylation levels for a, b, c, d, e, f, g, and h
were 40%, 33.7%, 79.1%, 4.2%, 0%, 3%, 32%, and 0.6%, respectively.
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methylation data were derived for the region upstream
of chr10:72605338-72605440. To identify methylation
differences among samples, we calculated the methyla-
tion level of all mapped Alu elements, and also that of
the structural variants present in the 19 loci verified.
This analysis revealed no methylation differences among
tissues (Additional File 4, Table S3).
Discussion
Recent studies demonstrated that major structural var-
iants in the human genome are derived from retrotran-
sposons, Alu elements in particular [16,41]. Due to the
extensive sequence homology that exists among young
Alu repeats, the identification of such structural variants
remains a challenging task. To date, a total of 2,558
polymorphic Alu retrotransposons have been reported
to occur in human populations, 1,763 of which have
been deposited in dbSNP and 795 in dbRIP. In this
study we implemented a computational pipeline to iden-
tify recent Alu insertions, and examined the methylation
status of the newly inserted Alu retrotransposons and
their flanking sequences. At the time we developed this
strategy the Genome Sequencer FLX System was the
most suitable alternative available, given the greater
length of the sequence reads that it generates, and the
fact that sequences would encompass an Alu repeat and
would be derived from bisulfite-converted genomic
DNA. Altogether, the longer reads generated with the
FLX System greatly facilitated their mapping back to the
CG
125 bp 0
*
a) chr10:72605338-72605440
0 425 bp
*
AA(A)n
b) chr2:48276482-48276601
123 bp 0
*
**
**
*
0 423 bp
*
AA(A)n
*
CG CG CG CGCG
123 bp 0
*
*
*
*
0 423 bp
*
AA(A)n
*
CG CG CG CGCG
**
*CG: CpG flanking the Alu insertion site
: Site of  Alu integration
: Newly inserted Alu element AA(A)n
Figure 4 Methylation statuses of two pairs of hemizygous alleles, i.e. before and after Alu insertions. a) chr10:72605338-72605440 locus;
b) chr2:48276482-48276601 locus. Schemes on the left side represent the allele not containing the Alu insertion, while the figure on the right
side represents the allele in which the Alu element inserted. The blue arrow indicates the probable site of Alu integration; CG and asterisk
indicate the CpG dinucleotides that are flanking the Alu element; red bar indicates the Alu element that was inserted.
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advantage, however, we anticipate that our approach
may be adapted to take advantage of competing next
generation sequencing platforms that have a higher
throughput and that can now generate sufficiently long
sequence reads.
Using this strategy a total of 327 putative Alu ele-
ments were identified. We found that 42.8% of their
insertion sites fell within intronic regions, while one
integration site mapped to the 3’-UTR of the TOMM40
gene. TOMM40 is a component of the preprotein trans-
locase complex of the outer mitochondrial membrane,
which consists of at least 7 different proteins (TOMM5,
TOMM6, TOMM7, TOMM20, TOMM22, TOMM40,
and TOMM70). These results are consistent with pre-
vious studies indicating that Alu retrotransposons tend
to be inserted within intragenic regions [1,42].
Out of the twenty-one insertion events that were ran-
domly selected for validation analysis, nineteen were
successfully verified. A limitation of the Alu-anchored
bisulfite PCR approach that needs to be acknowledged
i st h ef a c tt h a to n l y5 ’ flanking sequences are obtained.
The right arm of the Alu retrotransposons and their 3’
flanking sequences are not represented in the sequence
reads that are generated. Hence, in order to design pri-
mers for the validation experiments, we used the refer-
ence sequence of the human genome as source of
putative 3’-flanking sequences for the Alu insertions.
Accordingly, it is possible that the two cases that could
not be verified may have been caused by the utilization
of an incorrect 3’ flanking sequence for primer design.
Notwithstanding this limitation, the lowest estimated
accuracy for the analysis pipeline that we have imple-
mented in this study for the identification of de novo
Alu retrotransposition events would be of 90.5% (19/21).
The sequence features (TSD, TT/AAAA cleavage
sequence, and A-rich Alu tail) that are typically
observed in newly inserted Alu elements constitute hall-
marks of retrotransposition [5,10,36,37]. Indeed, further
analysis of the aforementioned nineteen PCR-cloned Alu
elements and flanking sequences revealed the presence
of both the TSD and TT/AAAA sites. Alu A-tails seem
to be an important factor to enable Alu element retro-
transposition [4,35]. Roy-Engel et al. reported that the
average A-tail length of active Alu elements is 26 [35].
Consistent to their finding, the Alu A-tail sizes of the
Alu elements described in this study ranged from 11-45
with an average of 29 bp.
Most cancer genomes are characterized by localized
hypermethylation as well as by global hypomethylation
[43,44]. This hypomethylation process may enable tran-
scription and de novo retrotransposition of Alu elements
which, in turn, may lead to genome instability [45]. Our
previous study demonstrated that the methylation level
of Alu elements decreased in ependymomas, and most
significantly in recurrent tumors [31]. To examine
whether some Alu insertions represented somatic events
limited to recurrent ependymomas, which could have
occurred in consequence of the loss of DNA methyla-
tion, we generated and compared PCR products from
ten genomic loci in primary and in recurrent tumors
derived from one individual. The same results were
obtained in all ten genomic loci. In addition, five of the
ten Alu insertions were also found in other individuals.
These results suggested that such validated Alu inser-
tions most likely represent germ-line rather than
somatic events.
In this study, in addition to identifying structural var-
iants in the genome of 6 individuals, we investigated
epigenetic variations that might result from de novo ret-
rotransponsition events. The Alu elements identified in
this study were heavily methylated, as it was previously
shown by high-throughput bisulfite sequencing and
herein validated by cloning and sequencing analyses.
The analysis of methylation throughout the mapped
Alus and among the 19 loci verified revealed that there
were no methylation differences among tissues (Addi-
tional File 4, Table S3). This result indicates that at least
by the time these DNA samples were obtained most of
the newly inserted Alu elements were already transcrip-
tionally repressed. This finding is further supported by
the fact that the promoters of the Alu elements, i.e.
their A and B boxes, were found to be methylated.
H o w e v e r ,t h e r ew a so n ee x c e p t i o n .W ef o u n da nA l u
insertion that was partially unmethylated
(chr9:37594172-37594310). Interestingly, the insertion of
this Alu element occurred 1,576 bp downstream from a
CpG island and 1,674 bp downstream from the tran-
scription start site of TOMM5, a gene encoding the
translocase of the outer mitochondrial membrane 5.
With a completely unmethylated promoter (both the A
box and the B box were unmethylated), it is conceivable
that this Alu element may have remained transcription-
ally active and hence have served as source for addi-
tional retrotransposition events. Another interesting
finding was that a CpG island that is upstream of the
element - i.e., that of TOMM5 - may be influencing the
methylation pattern of this Alu repeat. Indeed, the
methylation status of the CpG island was similar to that
of the 5’ end sequences of this Alu repeat, i.e. both were
unmethylated. It would be interesting to explore the
functional impact of this particular Alu on the nearby
TOMM5 gene. Additionally, 3 Alu repeats and 1 MIR
element that are localized between the newly inserted
Alu repeat and the CpG island were found to exhibit
very low methylation levels. Such striking pattern of
DNA methylation may indeed be an indication of the
influence exerted by the adjacent CpG island. It is also
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Page 9 of 13possible that other epigenetic factors might be affecting
the methylation statuses of these Alu elements, such as
nucleosome positioning. Two previous studies have
reported the influence of nucleosome positioning, within
and around Alu element, in Alu activity [46,47]. Accord-
ingly, it is noteworthy that an AluJo that is localized
downstream of this newly inserted Alu exhibits a similar
pattern of DNA methylation, i.e. its 5’ half is unmethy-
lated while its 3’ half is methylated. In our previous
study [32], we found that genomic localization has a
profound impact on Alu methylation status. In this
study, the identification of both methylated and
unmethylated Alu elements provided additional support
to there being a positional effect on Alu methylation.
Last, but not least, it is noteworthy that two of the
novel Alu insertions herein reported map within or near
genes encoding members of the preprotein translocase
complex of the outer mitochondrial membrane, namely
TOMM40 and TOMM5, respectively. It is conceivable
that given their housekeeping function and ubiquitous
expression pattern, hence commonly open chromatin
status, these genes may be more vulnerable to uptake de
novo retrotransposition events.
To explore the epigenetic impact of Alu insertion on
adjacent genomic sequences, we examined the methyla-
tion statuses for two loci harboring hemizygous inser-
tions, and - in one case - obtained the methylation
patterns of CpG dinucleotides flanking the Alu insertion
sites. Both alleles - irrespective of the presence of an
inserted element - were found to be heavily methylated,
and no significant epigenetic variation was observed in
association with the presence of the additional Alu
element.
Conclusions
In this work we have identified a few novel Alu inser-
tions sites. We used DNA samples from normal and
from tumor tissues, but the data obtained did not show
any tissue preference for these insertions. More studies
are highly desired to further scrutinize the functional
aspects of structural variants in the human genome,
including epigenetic variations that might arise in conse-
quence of a de novo retrotransposition event.
Methods
High-throughput bisulfite sequencing datasets for Alu
elements
The high-throughput bisulfite sequencing data were
derived from Alu-anchored bisulfite PCR libraries
derived from tissues samples, including a normal cere-
bellum, a normal 4
th ventricle lining, two primary non-
aggressive, two primary aggressive and two recurrent
ependymomas [31,32]. Briefly, genomic DNA is first
digested with AluI restriction enzyme, ligated to
adaptors and then subjected to bisulfite treatment. Bisul-
fite treated DNA is amplified with adaptor and Alu-spe-
cific primers, the latter targeting a large pool of CpG-
rich Alu elements. Thus, each PCR product contains the
5’end of an Alu element and its (most often) unique
flanking genomic sequence, which makes it possible for
each sequence to be unambiguously mapped to the
reference human genome. Primary non-aggressive epen-
dymomas are defined as primary tumors from patient
free of disease progression for more than 4 years and
primary aggressive ones are defined as primary tumors
from patients with recurrent disease within 3 years or
deceased of disease.
Computational pipeline for the identification of recent
Alu insertions
To identify putatively recent Alu insertions, sequence
reads rejected in previous studies were selected. Briefly,
after removal of primer and adaptor sequences,
sequences greater than 40 bp were aligned to the in
silico bisulfite converted reference genome using multi-
ple cycles of MegaBLAST. The word size used in Mega-
blast was set to 100 for the first cycle, it was decreased
by 20 for every cycle thereafter until the last, for which
the minimum length of best perfect match was set to
40. In addition, the identity percentage cutoff for a sig-
nificant alignment was set to be 100 for the last cycle
and 95 for all other cycles of Megablast [32]. The
sequence reads that mapped to genomic loci within 10
bp from an Alu element were considered as a putative
recent Alu insertion.
PCR, cloning, and sequencing
For PCR primer design, the original (not bisulfite con-
verted) DNA sequences flanking the predicted Alu
insertion sites were extracted from the UCSC reference
human genome, based on their genomic coordinates
[48]. PCR primers were designed in the region sur-
rounding the Alu insertion sites. PCR reactions were
performed using HotStartTaq
R Plus Master Mix from
QIAGEN. Each reaction was prepared as follows: 12.5
μL of HotStartTaq
R mix, 30 ng of DNA, 14 μMo fe a c h
primer, and enough water for 25 μL. The PCR reactions
were performed on a MJ Research machine (model PTC
225). Reactions were subjected to an initial activation
step of 95°C for 15 min, then by a denaturation step of
94°C for 1 min, followed by 40 cycles of 1 min at 94°C,
30 s at optimal annealing temperature, and 40 s at 72°C,
followed by a final extension step of 10 min at 72°C.
PCR product annealing temperatures (Tm) and primers
used on each reaction are listed on Additional File 5,
Table S4. After reactions were completed the amplified
fragments were separated using 1.5% agarose gel electro-
phoresis that was stained with ethidium bromide and
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carried out until a good separation of bands was
obtained. After separation in the 1.5% agarose gel the
bands were excised off the gel and purified using a gel
purification kit from QIAGEN, QIAquick
R PCR Purifica-
tion Kit. The purified PCR products were cloned using
the TOPO TA Cloning
R System from Invitrogen.
Sequencing reactions for individual colonies were con-
ducted at the Sequencing Core Facility of the Children’s
Memorial Research Center of Northwestern University’s
Feinberg School of Medicine.
Bisulfite PCR
Bisulfite conversion of genomic DNA was performed
with EZ DNA Methylation Gold kit (Zymo Research
Corporation, Irvine, CA) following the manufacturer’s
instructions. 300 ng of genomic DNA was treated and
eluted with 10 μL of elution solution. After this step,
DNA from the chr10:72275361-72275449 genomic locus
was amplified using the pair of primers: 5’-G G AT T A
AGT TTT TTT TTT GTT T -3’ and 5’-C T AC A A
AAA AAA ATA ACT CAT A -3’; the chr2:48129974-
48130105 genomic locus was amplified using the pair of
primers: 5’- CCT TAC CAT TTA AAA ATA AAA
AAT CAA -3’ and 5’- GTT TAA GAT TTA AAG GAA
TGA GTT AG -3’. PCR reactions were prepared using
the same reagents and conditions described above. The
PCR program used was: activation step of 95°C for 15
min, then by a denaturation step of 94°C for 1 min, fol-
lowed by 40 cycles of 1 min at 94°C, 30 s at optimal
annealing temperature (49°C for locus chr10:72605338-
72605440 and 42°C for locus chr2:48276482-48276601),
and 40 s at 72°C, followed by a final extension step of
10 min at 72°C. PCR amplified fragments were separated
in 1.5% agarose and excised from it as described above.
To amplify the 5’e n do ft h eC p Gi s l a n da n dt h e
sequence flanking the 3’ end of the Alu element (AI19
chr9:37594172-37594310) we used nested PCR. The pri-
mers used for the CpG island were: external primers
(TOMM5-eFor 5’- AAG TTG GGA GAA TTA GGA
TGA TT -3’ and TOMM5-eRev 5’- CTA ATT TTT
ATA TAA CAA ATA TTA TTA AAA ACA AC -3’),
internal primers (TOMM5-iFor 5’- GTA TTT TTA
GAG TTA AGG GGT GT -3’ and TOMM5-iRev 5’-
CAC TTC AAA TCA ACT AAA TCA AAA C -3’). The
primers used for the 3’Alu flanking sequence were:
external primers (ch9Down-eFor 5’-T T TG T AG T G
ATG TTG AAA GTA GTA AGA- 3’ and ch9Down-
eRev 5’- AAT ATA TAC CTT CCC TTT CCA ACT
-3’), internal primers (ch9Down-iFor 5’- TTT ATT TTA
GAT TGA GTT TTG TTT TGT -3’ and ch9Down-iRev
5’- CTT AAA CCC AAA AAT ATA AAA TTA CAA
TAC -3’) .T h eP C Rp r o g r a mu s e dw a st h es a m e
mentioned above, the TM temperatures were 51°C for
external primers and 50°C for internal primers.
Alu classification
As it was mentioned above, the initial data used for
this study were derived from Alu-anchored bisulfite
PCR libraries. These libraries were constructed using
primers specially designed to target the most recent
and active Alu elements, which are the ones that
belong to AluY family. To classify the Alu insertions
verified in this study within the AluY family, we
aligned the sequences generated in this study with
those contained in the UCSC Genome browser. From
this alignment, the element with the highest score was
used to classify a newly identified Alu insertion into
the AluY family.
Additional material
Additional file 1: Table S1. Putatively recent Alu insertions. Alu
insertions identified in eight Alu bisulfite PCR libraries.
Additional file 2: Table S2. Clusters of putative Alu insertions. Alu
insertions and their gene annotation.
Additional file 3: Figure S1. Methylation pattern of recent Alu
insertions. To determine the methylation status, the sequences
corresponding to the first half of Alu elements plus its 5’ flanking regions
[31,32] were aligned to the Alu element sequences generated in this
study. NC1: Normal cerebellum and NC2: normal 4
th ventricle lining
tissue; PA1, PA2, PA3, PA4, and PA5: primary ependymoma tumor; RL:
ependymoma tumor relapsed from PA3.
Additional file 4: Table S3. Alu methylation level. Methylation levels of
mapped and 19 non-mapped Alu elements.
Additional file 5: Table S4. Validation of identified Alu elements.
Primers designed for Alu elements validation.
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